The Role of Secondary Surgery in Recurrent Ovarian Cancer

Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, D., Mancini, M., Di Rocco, R., Fontanelli, R., Raspagliesi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420128/
https://www.ncbi.nlm.nih.gov/pubmed/22919475
http://dx.doi.org/10.1155/2012/613980
_version_ 1782240808647262208
author Lorusso, D.
Mancini, M.
Di Rocco, R.
Fontanelli, R.
Raspagliesi, F.
author_facet Lorusso, D.
Mancini, M.
Di Rocco, R.
Fontanelli, R.
Raspagliesi, F.
author_sort Lorusso, D.
collection PubMed
description Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.
format Online
Article
Text
id pubmed-3420128
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34201282012-08-23 The Role of Secondary Surgery in Recurrent Ovarian Cancer Lorusso, D. Mancini, M. Di Rocco, R. Fontanelli, R. Raspagliesi, F. Int J Surg Oncol Review Article Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described. Hindawi Publishing Corporation 2012 2012-08-05 /pmc/articles/PMC3420128/ /pubmed/22919475 http://dx.doi.org/10.1155/2012/613980 Text en Copyright © 2012 D. Lorusso et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lorusso, D.
Mancini, M.
Di Rocco, R.
Fontanelli, R.
Raspagliesi, F.
The Role of Secondary Surgery in Recurrent Ovarian Cancer
title The Role of Secondary Surgery in Recurrent Ovarian Cancer
title_full The Role of Secondary Surgery in Recurrent Ovarian Cancer
title_fullStr The Role of Secondary Surgery in Recurrent Ovarian Cancer
title_full_unstemmed The Role of Secondary Surgery in Recurrent Ovarian Cancer
title_short The Role of Secondary Surgery in Recurrent Ovarian Cancer
title_sort role of secondary surgery in recurrent ovarian cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420128/
https://www.ncbi.nlm.nih.gov/pubmed/22919475
http://dx.doi.org/10.1155/2012/613980
work_keys_str_mv AT lorussod theroleofsecondarysurgeryinrecurrentovariancancer
AT mancinim theroleofsecondarysurgeryinrecurrentovariancancer
AT diroccor theroleofsecondarysurgeryinrecurrentovariancancer
AT fontanellir theroleofsecondarysurgeryinrecurrentovariancancer
AT raspagliesif theroleofsecondarysurgeryinrecurrentovariancancer
AT lorussod roleofsecondarysurgeryinrecurrentovariancancer
AT mancinim roleofsecondarysurgeryinrecurrentovariancancer
AT diroccor roleofsecondarysurgeryinrecurrentovariancancer
AT fontanellir roleofsecondarysurgeryinrecurrentovariancancer
AT raspagliesif roleofsecondarysurgeryinrecurrentovariancancer

Ejemplares similares